<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74206</article-id><article-id pub-id-type="doi">10.7554/eLife.74206</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Pathogen infection and cholesterol deficiency activate the <italic>C. elegans</italic> p38 immune pathway through a TIR-1/SARM1 phase transition</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-256380"><name><surname>Peterson</surname><given-names>Nicholas D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4157-8119</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-240225"><name><surname>Icso</surname><given-names>Janneke D</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256381"><name><surname>Salisbury</surname><given-names>J. Elizabeth</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-256382"><name><surname>Rodríguez</surname><given-names>Tomás</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8724-5427</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-79552"><name><surname>Thompson</surname><given-names>Paul R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1621-3372</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-165760"><name><surname>Pukkila-Worley</surname><given-names>Read</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5340-8294</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Program in Innate Immunity</institution>, <institution>University of Massachusetts Chan Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Program in Chemical Biology</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">RNA Therapeutics Institute</institution>, <institution>University of Massachusetts Chan Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Biochemistry and Pharmacology</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-119040"><name><surname>Gruber</surname><given-names>Jan</given-names></name><role>Reviewing editor</role><aff><institution>Yale-NUS College</institution>, <country>Singapore</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Paul.Thompson@umassmed.edu</email> (PT);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>read.pukkila-worley@umassmed.edu</email> (RP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>31</day><month>01</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e74206</elocation-id><history><date date-type="received"><day>25</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>28</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Peterson et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Peterson et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74206-v1.pdf"/><abstract><p>Intracellular signaling regulators can be concentrated into membrane-free, higher-ordered protein assemblies to initiate protective responses during stress - a process known as phase transition. Here, we show that a phase transition of the <italic>Caenorhabditis elegans</italic> Toll/interleukin-1 receptor domain protein (TIR-1), an NAD<sup>+</sup> glycohydrolase homologous to mammalian sterile alpha and TIR motif-containing 1 (SARM1), underlies p38 PMK-1 immune pathway activation in <italic>C. elegans </italic>intestinal epithelial cells. Through visualization of fluorescently labeled TIR-1/SARM1 protein, we demonstrate that physiologic stresses, both pathogen and non-pathogen, induce multimerization of TIR-1/SARM1 into visible puncta within intestinal epithelial cells. <italic>In vitro</italic> enzyme kinetic analyses revealed that, like mammalian SARM1, the NAD<sup>+</sup> glycohydrolase activity of <italic>C. elegans</italic> TIR-1 is dramatically potentiated by protein oligomerization and a phase transition. Accordingly, <italic>C. elegans</italic> with genetic mutations that specifically block either multimerization or the NAD<sup>+</sup> glycohydrolase activity of TIR-1/SARM1 fail to induce p38 PMK phosphorylation, are unable to increase immune effector expression, and are dramatically susceptible to bacterial infection. Finally, we demonstrate that a loss-of-function mutation in <italic>nhr-8</italic>, which alters cholesterol metabolism and is used to study conditions of sterol deficiency, causes TIR-1/SARM1 to oligomerize into puncta in intestinal epithelial cells. Cholesterol scarcity increases p38 PMK-1 phosphorylation, primes immune effector induction in a manner that requires TIR-1/SARM1 oligomerization and its intrinsic NAD<sup>+</sup> glycohydrolase activity, and reduces pathogen accumulation in the intestine during a subsequent infection. These data reveal a new adaptive response that allows a metazoan host to anticipate pathogen threats during cholesterol deprivation, a time of relative susceptibility to infection. Thus, a phase transition of TIR-1/SARM1 as a prerequisite for its NAD<sup>+</sup> glycohydrolase activity is strongly conserved across millions of years of evolution and is essential for diverse physiological processes in multiple cell types.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01 AI130289</award-id><principal-award-recipient><name><surname>Pukkila-Worley</surname><given-names>Read</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01 AI159159</award-id><principal-award-recipient><name><surname>Pukkila-Worley</surname><given-names>Read</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R21 AI163430</award-id><principal-award-recipient><name><surname>Pukkila-Worley</surname><given-names>Read</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009576</institution-id><institution>Kenneth Rainin Foundation</institution></institution-wrap></funding-source><award-id>Innovator Award</award-id><principal-award-recipient><name><surname>Pukkila-Worley</surname><given-names>Read</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>F30 AI150127</award-id><principal-award-recipient><name><surname>Peterson</surname><given-names>Nicholas D</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>T32 AI132152</award-id><principal-award-recipient><name><surname>Peterson</surname><given-names>Nicholas D</given-names></name><name><surname>Icso</surname><given-names>Janneke D</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>T32 GM107000</award-id><principal-award-recipient><name><surname>Peterson</surname><given-names>Nicholas D</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>F31 NS122423</award-id><principal-award-recipient><name><surname>Icso</surname><given-names>Janneke D</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35 GM118112</award-id><principal-award-recipient><name><surname>Thompson</surname><given-names>Paul R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The mRNA-seq datasets are available from the NCBI Gene Expression Omnibus using the accession numbers GSE178572 and GSE190585.Source data files are provided for all figures.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Peterson ND</collab><collab>Pukkila-Worley R</collab></person-group><year iso-8601-date="2021">2021</year><source>Sterol scarcity primes p38 immune defenses through a TIR-1/SARM1 phase transition</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178572">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE178572</ext-link><comment>NCBI Gene Expression Omnibus, GSE178572</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Peterson ND</collab><collab>Pukkila-Worley R</collab></person-group><year iso-8601-date="2021">2021</year><source>Pathogen infection and cholesterol deficiency activate the C. elegans p38 immune pathway through a TIR-1/SARM1 phase transition</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190585">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE190585</ext-link><comment>NCBI Gene Expression Omnibus, GSE190585</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Fletcher M</collab><collab>Butty V</collab><collab>Kim DH</collab></person-group><year iso-8601-date="2019">2019</year><source>Transcriptional profiling of C. elegans on pathogenic Pseudomonas aeruginosa</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE119292">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE119292</ext-link><comment>NCBI Gene Expression Omnibus, GSE119292</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-74206-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>